Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Takeda, Amgen to suspend trials of cancer drug
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Japan's Takeda Pharmaceutical Co and U.S. biotech firm Amgen Inc said they would suspend enrolment in the last-stage trials of a key cancer drug candidate following negative study results.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Non-safety-related voluntary recall of a limited portion of Daytrana (methylphenidate transdermal system) patches announced
Shire, 12/07/09